Search filters

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 26 January 2010
Author/s

author: Gregor Verhoef  Bob Löwenberg  Pieter Sonneveld  Harry Schouten  Hartmut Döhner  Johan Maertens  Alois Gratwohl 

Publication date January 26, 2010
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item